Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Peripheral Vascular Disease
Interventions
DRUG

Remodulin (treprostinil sodium) Injection

Trial Locations (4)

12208

Vascular Institute Albany Medical College, Albany

62702

Southern Illinois University School of Medicine, Springfield

97239

Oregon Health Sciences University, Portland

01655

University of Massachusetts Memorial Health Center, Worcester

Sponsors
All Listed Sponsors
lead

United Therapeutics

INDUSTRY

NCT00067041 - Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft | Biotech Hunter | Biotech Hunter